Atrys Health SL (ATRY) - Total Liabilities

Latest as of June 2025: €337.61 Million EUR ≈ $394.70 Million USD

Based on the latest financial reports, Atrys Health SL (ATRY) has total liabilities worth €337.61 Million EUR (≈ $394.70 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Atrys Health SL generate cash to assess how effectively this company generates cash.

Atrys Health SL - Total Liabilities Trend (2012–2024)

This chart illustrates how Atrys Health SL's total liabilities have evolved over time, based on quarterly financial data. Check Atrys Health SL (ATRY) asset resilience to evaluate the company's liquid asset resilience ratio.

Atrys Health SL Competitors by Total Liabilities

The table below lists competitors of Atrys Health SL ranked by their total liabilities.

Company	Country	Total Liabilities
Victory Supermarket Chain Ltd TA:VCTR	Israel	ILA1.75 Billion
The Gold Bond Group Ltd TA:GOLD	Israel	ILA249.93 Million
Darwin Precisions Corp TW:6120	Taiwan	NT$7.66 Billion
Old Point Financial Corporation NASDAQ:OPOF	USA	$1.28 Billion
Tureks Turizm Tasimacilik AS IS:TUREX	Turkey	TL243.17 Million
Blue Acquisition Corp. Class A Ordinary Shares NASDAQ:BACC	USA	$8.12 Million
Creative Sensor Inc TW:8249	Taiwan	NT$2.45 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Atrys Health SL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ATRY stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Atrys Health SL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Atrys Health SL (2012–2024)

The table below shows the annual total liabilities of Atrys Health SL from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€330.95 Million ≈ $386.92 Million	-2.41%
2023-12-31	€339.12 Million ≈ $396.47 Million	-7.77%
2022-12-31	€367.71 Million ≈ $429.89 Million	+26.08%
2021-12-31	€291.65 Million ≈ $340.97 Million	+190.35%
2020-12-31	€100.45 Million ≈ $117.43 Million	+108.88%
2019-12-31	€48.09 Million ≈ $56.22 Million	+76.47%
2018-12-31	€27.25 Million ≈ $31.86 Million	+61.25%
2017-12-31	€16.90 Million ≈ $19.76 Million	+3.64%
2016-12-31	€16.31 Million ≈ $19.06 Million	+13.27%
2015-12-31	€14.40 Million ≈ $16.83 Million	+14.17%
2014-12-31	€12.61 Million ≈ $14.74 Million	+2.90%
2013-12-31	€12.25 Million ≈ $14.33 Million	+0.14%
2012-12-31	€12.24 Million ≈ $14.31 Million	--

About Atrys Health SL

MC:ATRY Spain Biotechnology

Market Cap

$244.51 Million

€209.15 Million EUR

Market Cap Rank

#16273 Global

#106 in Spain

Share Price

€2.76

Change (1 day)

-2.30%

52-Week Range

€2.51 - €3.51

All Time High

€11.20